Skip to Main Content

Paper Details

A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral Load.
Clin Infect Dis
42
2022
Bamlanivimab, COVID-19, Patients, SARS, SARS-CoV-2, bamlanivimab, etesevimab, patient, patients
Author NameAffiliation
Gregory D Huhn
Andra L BlomkalnsStanford University School of Medicine
Philip J Ebert
  • 1 - 3

Datasets

Release 1.2